AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...

First-in-human DS3790 trial tests a CD37-targeted ADC for relapsed/refractory B-cell non-Hodgkin lymphoma, aiming to improve response durability and survival. In a milestone for the hematologic ...

NEO-811 is a novel molecular glue degrader intended to fully block a key clear cell renal cell carcinoma signaling pathway via cereblon-dependent target degradation. The primary outcome measures for ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) today announced that the first patients have been dosed in the Phase 2 portion of its ...

TL;DR: Thunderobot's MIX GAMING 2 Mini-PC, showcased at CES 2026, delivers powerful 4K @ 120FPS gaming with up to an Intel Core Ultra 9 275HX CPU and NVIDIA GeForce RTX 5090 GPU. It features advanced ...

Systemic Olvi-Vec administration in lung cancer trials shows feasibility, tolerability, and promising clinical responses in heavily pretreated patients. OLVI-VEC-SCLC-202 trial in SCLC shows a 33% ...

Melissa Sarnowski has been a game writer for over two years. While she's willing to dig into any game for an article, she heavily focuses on The Legend of Zelda, Resident Evil, Final Fantasy, and The ...

The biggest stories of the day delivered to your inbox.

Beam Therapeutics Inc. (NASDAQ:BEAM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 2, 2025, that Beam Therapeutics Inc. (NASDAQ:BEAM) has released revised safety and ...

(RTTNews) - Monte Rosa Therapeutics, Inc. (GLUE) today will present updated interim results from its ongoing Phase 1/2 study of MRT-2359 in patients with metastatic castration-resistant prostate ...

SAN DIEGO, Dec. 9, 2025 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that they will ...